---
authors:
  - bruno-amaral
date: 2025-04-11T22:24:11Z
description: "Gregory AI for Multiple Sclerosis research. Activities, and accounts for the project in 2024."
draft: false
resources: 
- src: images/gregory-ms-2024.png
  name: "thumb"
- src: images/gregoryai_background.png
  name: "header"

slug:

subtitle: 
tags: 
  - 
categories: 
  - 
title: "2024 Gregory MS Review"

options:
  unlisted: false
  showHeader: true
  hideFooter: false
  hideSubscribeForm: false
  header: mini
scripts:
  -
---
</div>
<div class="container">

## Executive Summary

**2024 marked a pivotal year for Gregory AI**, with significant expansions in functionality, partnerships, and community reach. Key achievements include enhanced clinical trial coverage, and our first year of financial self-sustainability.

---

## Key Metrics for 2024

<section class="py-4">
  <div class="container">
    <div class="row">
      <div class="col-md-3 mb-3">
        <div class="card border-0 bg-gradient-primary  h-100">
          <div class="card-body text-center py-4">
            <div class="icon icon-shape bg-white text-primary rounded-circle mb-3 mx-auto">
              <i class="fas fa-file-alt"></i>
            </div>
            <h4 class=" mb-1">30,000+</h4>
            <p class="mb-0 opacity-8 small text-dark">Research Articles</p>
          </div>
        </div>
      </div>
      <div class="col-md-3 mb-3">
        <div class="card border-0 bg-gradient-info  h-100">
          <div class="card-body text-center py-4">
            <div class="icon icon-shape bg-white text-info rounded-circle mb-3 mx-auto">
              <i class="fas fa-flask"></i>
            </div>
            <h4 class=" mb-1">5,000+</h4>
            <p class="mb-0 opacity-8 small">Clinical Trials</p>
          </div>
        </div>
      </div>
      <div class="col-md-3 mb-3">
        <div class="card border-0 bg-gradient-success  h-100">
          <div class="card-body text-center py-4">
            <div class="icon icon-shape bg-white text-success rounded-circle mb-3 mx-auto">
              <i class="fas fa-users"></i>
            </div>
            <h4 class=" mb-1">160+</h4>
            <p class="mb-0 opacity-8 small">Subscribers</p>
          </div>
        </div>
      </div>
      <div class="col-md-3 mb-3">
        <div class="card border-0 bg-gradient-warning  h-100">
          <div class="card-body text-center py-4">
            <div class="icon icon-shape bg-white text-warning rounded-circle mb-3 mx-auto">
              <i class="fas fa-chart-line"></i>
            </div>
            <h4 class=" mb-1">First Year</h4>
            <p class="mb-0 opacity-8 small">Self-Sustainability</p>
          </div>
        </div>
      </div>
    </div>
  </div>
</section>

---

<div class="text-center">
  <a class="btn btn-success" href="./GregoryMS_Annual_Report_2024.pdf" data-umami-event="click--download-pdf-2024" target="_blank">
    Download PDF Report 
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512" style="height: 1rem; vertical-align: middle; opacity: 0.8">
      <path fill="#ffffff" d="M288 32c0-17.7-14.3-32-32-32s-32 14.3-32 32V274.7l-73.4-73.4c-12.5-12.5-32.8-12.5-45.3 0s-12.5 32.8 0 45.3l128 128c12.5 12.5 32.8 12.5 45.3 0l128-128c12.5-12.5 12.5-32.8 0-45.3s-32.8-12.5-45.3 0L288 274.7V32zM64 352c-35.3 0-64 28.7-64 64v32c0 35.3 28.7 64 64 64H448c35.3 0 64-28.7 64-64V416c0-35.3-28.7-64-64-64H346.5l-45.3 45.3c-25 25-65.5 25-90.5 0L165.5 352H64zm368 56a24 24 0 1 1 0 48 24 24 0 1 1 0-48z"/>
    </svg>
  </a>
</div>

---

The project is still called Gregory‑MS, but we refer to the software as Gregory‑AI. We chose this name because "MS" might suggest it only works for Multiple Sclerosis. In fact, the software can adapt to other diseases and medical research areas.

---

## Development and Collaborations

<section class="py-4">
  <div class="container">
    <div class="row">
      <div class="col-md-6 mb-4">
        <div class="card h-100 border-0 shadow-sm">
          <div class="card-body">
            <div class="d-flex align-items-center mb-3">
              <h5 class="mb-0 title" > <i class="fas fa-brain text-primary"></i> Gregory AI Enhancements</h5>
            </div>
            <p class="">
              We expanded Gregory AI's capabilities to support multiple research subjects on a single platform. This flexible approach benefits not just MS research but also other areas such as brain regeneration, enabling diverse research teams to tap into up-to-date data and findings.
            </p>
          </div>
        </div>
      </div>
      <div class="col-md-6 mb-4">
        <div class="card h-100 border-0 shadow-sm">
          <div class="card-body">
            <div class="d-flex align-items-center mb-3">
              <h5 class="mb-0 title"><i class="fas fa-envelope text-info"></i> Email List Overhaul</h5>
            </div>
            <p class="">
              We completely redesigned the email alert system, giving researchers, healthcare professionals, and patients more options to subscribe to precisely the information they need — be it new articles, clinical trials, or administrative summaries.
            </p>
          </div>
        </div>
      </div>
      <div class="col-md-6 mb-4">
        <div class="card h-100 border-0 shadow-sm">
          <div class="card-body">
            <div class="d-flex align-items-center mb-3">
              <h5 class="mb-0 title"><i class="fas fa-clipboard-list text-success"></i> New Clinical Trial Registry</h5>
            </div>
            <p class="">
              Adding the <a href="https://euclinicaltrials.eu/" target="_blank">Clinical Trial Information System (CTIS)</a> as a source means users get even more complete coverage of trials around the globe. Gregory AI can now track changes or new listings from the largest registries worldwide.
            </p>
          </div>
        </div>
      </div>
      <div class="col-md-6 mb-4">
        <div class="card h-100 border-0 shadow-sm">
          <div class="card-body">
            <div class="d-flex align-items-center mb-3">
              <h5 class="mb-0 title"><i class="fas fa-handshake text-warning"></i> REGENERAR and GENIE Collaborations</h5>
            </div>
            <p class="">
              Two new clinical research groups — <a href="https://research.regenerar.eu/" target="_blank">REGENERAR for brain regeneration</a> and <a href="https://investigacao.encefalites.pt/" target="_blank">GENIE for autoimmune encephalitis</a> — are using Gregory AI as a real-time map of relevant studies.
            </p>
          </div>
        </div>
      </div>
    </div>
  </div>
</section>

## Observatories and Research Insights

<section class="py-4">
  <div class="container">
    <div class="row">
      <div class="col-md-6 mb-4">
        <div class="card h-100 border-0 shadow-sm bg-light">
          <div class="card-body">
            <div class="d-flex align-items-center mb-3">
              <h5 class="mb-0 title"><i class="fas fa-microscope text-primary"></i> Brain Regeneration Focus</h5>
            </div>
            <p class="text-muted">
              Following our conversations with the Horizon Europe-funded REGENERAR project, we launched a dedicated instance of Gregory AI to gather and share studies about neurological repair. This marks a step toward assisting other neurodegenerative conditions beyond MS.
            </p>
          </div>
        </div>
      </div>
      <div class="col-md-6 mb-4">
        <div class="card h-100 border-0 shadow-sm bg-light">
          <div class="card-body">
            <div class="d-flex align-items-center mb-3">
              <h5 class="mb-0 title"><i class="fas fa-search text-info"></i> Continued MS Monitoring</h5>
            </div>
            <p class="text-muted">
              While we broadened our scope, MS remains a priority. We're refining algorithms developed in part with Nova SBE's Project-Based Learning Program to better identify papers addressing patient outcomes, providing more tangible, patient-focused insights.
            </p>
          </div>
        </div>
      </div>
    </div>
  </div>
</section>

## Clinical Trials and Data Expansion

<section class="py-4">
  <div class="container">
    <div class="card border-0 shadow-sm">
      <div class="card-body p-4">
        <div class="row align-items-center">
          <div class="col-md-8">
            <div class="d-flex align-items-center mb-3">
              <h5 class="mb-0 title"><i class="fas fa-globe text-info"></i> Expanded Global Coverage</h5>
            </div>
            <p class="text-muted mb-3">
              We added the Clinical Trial Information System (CTIS) alongside existing sources like ClinicalTrials.gov and the WHO registry, strengthening our ability to track new research across continents.
            </p>
            <p class="text-muted mb-0">
              <strong>Result:</strong> More comprehensive trial coverage means researchers and patients have access to the most complete picture of ongoing studies worldwide.
            </p>
          </div>
          <div class="col-md-4 text-center">
            <div class="p-3 bg-light rounded">
              <i class="fas fa-database fa-3x text-info mb-3"></i>
              <h6 class="text-info mb-1">5,000+</h6>
              <p class="text-muted small mb-0">Clinical Trials Tracked</p>
            </div>
          </div>
        </div>
      </div>
    </div>
  </div>
</section>

## Financial Transparency & Community Support

<section class="py-4">
  <div class="container">
    <div class="card border-0 shadow">
      <div class="card-body p-4">
        <div class="row align-items-center">
          <div class="col-md-8">
            <div class="d-flex align-items-center mb-3">
              <h5 class="mb-0 title"><i class="fas fa-hand-holding-heart text-success"></i> First Year of Self-Sustainability</h5>
            </div>
            <p class="text-muted mb-3">
              Thanks to generous donations from our community, Gregory AI achieved its first year of financial self-sustainability, covering hosting costs, email services, and platform improvements without external funding.
            </p>
            <p class="text-muted mb-0">
              <strong>Community Growth:</strong> We welcomed over 160 new subscribers in 2024, with the majority identifying as patients, alongside a growing segment of doctors, researchers, and clinical centers.
            </p>
          </div>
          <div class="col-md-4 text-center">
            <div class="p-3 bg-light rounded">
              <i class="fas fa-chart-line fa-3x text-success mb-3"></i>
              <h6 class="text-success mb-1">100%</h6>
              <p class="text-muted small mb-0">Self-Sustained Operations</p>
            </div>
          </div>
        </div>
      </div>
    </div>
    <div class="mt-4">
      {{< recent-donations style="compact" >}}
    </div>
    <div class="row mt-4">
      <div class="col-12 text-center">
        <a href="/annual-review/)" class="btn btn-outline-primary me-3">
          <i class="fas fa-chart-bar me-2"></i>View Our Activities and Financial Reports
        </a>
        <a href="/donations/" class="btn btn-primary">
          <i class="fas fa-heart me-2"></i>Support Our Mission
        </a>
      </div>
    </div>
  </div>
</section>

## Advancements in Clinical Trials

- **Expanded Coverage**  
  As mentioned before, we added CTIS alongside existing sources like ClinicalTrials.gov and the WHO registry. We've strengthened our ability to track new research across continents.

## Financial Overview and Team Contributions

- **First Year of Self-Sustainability**  
  Thanks to generous donations, Gregory MS managed to shoulder a greater share of its hosting and email costs. This financial independence underlines the community’s trust in the project and its goals.

- **Key Numbers for 2024**  
  Our database now has over 30,000 articles and over 5,000 clinical trials. We also welcomed over 160 subscribers, with the majority identifying as patients, but a growing segment of doctors, researchers, and clinical centers.

- **New Team Member**  
  We’re delighted to introduce *Micaela Gonçalves*, who brings a fresh perspective and energy.

## Team & Community Growth

<section class="py-4">
  <div class="container">
    <div class="row">
      <div class="col-md-6 mb-4">
        <div class="card h-100 border-0 shadow-sm">
          <div class="card-body">
            <div class="d-flex align-items-center mb-3">
              <h5 class="mb-0 title"><i class="fas fa-user-plus text-success"></i> New Team Member</h5>
            </div>
            <p class="text-muted">
              We're delighted to introduce <strong>Micaela Gonçalves</strong>, who brings fresh perspective and energy to our growing team, helping us expand our reach and impact in the MS research community.
            </p>
          </div>
        </div>
      </div>
      <div class="col-md-6 mb-4">
        <div class="card h-100 border-0 shadow-sm">
          <div class="card-body">
            <div class="d-flex align-items-center mb-3">
              <h5 class="mb-0 title"><i class="fas fa-users text-primary"></i> Community Engagement</h5>
            </div>
            <p class="text-muted">
              We continue to listen to feedback from patients, healthcare professionals, and researchers, using their insights to develop new features and improve the platform's usability and relevance.
            </p>
          </div>
        </div>
      </div>
    </div>
  </div>
</section>

## Media & Social Presence

<section class="py-4">
  <div class="container">
    <div class="card border-0 shadow-sm">
      <div class="card-body p-4">
        <div class="d-flex align-items-center mb-3">
          <h5 class="mb-0 title"><i class="fas fa-share-alt text-info"></i> Growing Social Media Presence</h5>
        </div>
        <p class="text-muted mb-3">
          While changes in social media policies continue, our presence on <a href="https://med-mastodon.com/@gregoryMS" target="_blank">Mastodon (@gregory-ms@med-mastodon.com)</a> and <a href="https://bsky.app/profile/Gregory-MS.com" target="_blank">BlueSky (@Gregory-MS.com)</a> has grown.
        </p>
        <p class="text-muted mb-0">
          <strong>Automated Updates:</strong> Our social media automation ensures the MS community can quickly see newly published research and clinical trials as they become available.
        </p>
      </div>
    </div>
  </div>
</section>

## Looking Forward: 2025 Aspirations

<section class="py-4">
  <div class="container">
    <div class="row">
      <div class="col-md-6 mb-4">
        <div class="card h-100 border-0 shadow-sm bg-light">
          <div class="card-body">
            <div class="d-flex align-items-center mb-3">
              <h5 class="mb-0 title"><i class="fas fa-robot text-primary"></i> Refining AI Models</h5>
            </div>
            <p class="text-muted">
              Implementing the NOVA SBE algorithm remains a top priority. We want to improve our content recommendations to highlight studies with measurable patient outcomes, making research more actionable for the MS community.
            </p>
          </div>
        </div>
      </div>      
      <div class="col-md-6 mb-4">
        <div class="card h-100 border-0 shadow-sm bg-light">
          <div class="card-body">
            <div class="d-flex align-items-center mb-3">
              <h5 class="mb-0 title"><i class="fas fa-handshake text-success"></i> Expanding Collaborations</h5>
            </div>
            <p class="text-muted">
              Beyond REGENERAR and GENIE, we aim to extend partnerships with clinical research organizations, innovators, and patient advocacy groups to maximize our impact on neurological research.
            </p>
          </div>
        </div>
      </div>
    </div>
  </div>
</section>

</div>